Empiric treatment of patients with sepsis and septic shock and place in therapy of cefiderocol: a systematic review and expert opinion statement
Abstract Carbapenem-resistant Gram-negative bacteria are frequent causes of sepsis and septic shock in intensive care unit (ICU) and thus considered a public health threat. Until now, the best available therapies consist of combinations of preexisting or new antibiotics with β-lactamase inhibitors (...
Main Authors: | Andrea Cortegiani, Giulia Ingoglia, Mariachiara Ippolito, Massimo Girardis, Marco Falcone, Federico Pea, Francesco Pugliese, Stefania Stefani, Pierluigi Viale, Antonino Giarratano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Journal of Anesthesia, Analgesia and Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s44158-022-00062-7 |
Similar Items
-
Erratum: Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
by: Frontiers Production Office
Published: (2022-08-01) -
Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
by: Pierluigi Viale, et al.
Published: (2023-06-01) -
Clinical Outcome of Cefiderocol for Infections with Carbapenem-Resistant Organisms
by: Monirul I. Sajib, et al.
Published: (2023-05-01) -
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections
by: Amer El Ghali, et al.
Published: (2024-02-01) -
Cefiderocol Efficacy in a Real-Life Setting: Single-Centre Retrospective Study
by: Gabriele Palermo, et al.
Published: (2023-04-01)